Virtual health platform offers an additional pathway to care for the more than 45 million people in the U.S. living with eczema, seborrheic dermatitis, and plaque psoriasisConnects eligible ...

Publisher Arc System Works and developer UnitePlus have announced “tactical counter-timeline RPG” Qliphah in Providence’s Shadow. It will launch for PlayStation 5, Switch, and PC ...

Korea Research Institute of Standards and Science has developed a toxicity assessment system that automatically measures and analyzes the heart rate of Daphnia magna. Capable of processing heart rate ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The 2026 Kia Carnival MPV Hybrid is the anti-minivan minivan. Despite its distinctive ...

In this playlist, I show you how to understand set theory. I introduce sets as Venn diagrams, mapping, and as sets of numbers. With sets, we look at how to find the union, complement, and intersection ...

April 27 (Reuters) - Meta Platforms (META.O), opens new tab has signed an agreement with Overview Energy to secure power from the startup's space-based solar energy infrastructure for the Facebook ...

C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare kidney conditions caused by an overactive complement system, part of the immune system. C3G ...

Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...

Complement Drug For Kidney Disease Market Analysis and Strategic Overview for 2026 The global market for complement drugs targeting kidney disease is poised for substantial growth by 2026, driven by ...

United States-based space solar startup Overview Energy has announced its emergence from stealth mode to work on the next phase of commercialization. Based in Ashburn, Virginia, the company was ...

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...